商品化血小板病原体灭活技术的应用现状及质量评价

Current Status of Application and Quality Evaluation of Commercial Platelet Pathogen Reduction Technology

随着输血医学的发展,血小板病原体污染问题越来越受到行业的关注。目前病原体灭活技术(PRT)已经成功应用于血小板并取得了很好的效果。本文对已经商品化的血小板PRT研究进展进行概述,对血小板PRT的应用现状、临床前机制研究、临床队列研究及替代或补充策略等方面的内容进行综合分析并提出建议,为保障我国血液安全、开发适用于我国国情的血小板PRT产品提供科学依据。

With the development of transfusion medicine,platelet pathogen contamination is of increasing concern to the industry.Currently,pathogen reduction technology(PRT)has been successfully applied to platelets and achieved good results.This paper provides an overview of the research progress of commercial platelet PRT,a comprehensive analysis of the current application status of platelet PRT,preclinical mechanism studies,clinical cohort studies and alternative or complementary strategies,and makes recommendations to provide a scientific basis for safeguarding blood safety in China and developing platelet PRT products applicable to our national conditions.